The remaining 144 articles were subjected to full‐text review, with 129 excluded due to factors such as irrelevant outcomes related to VEGF‐A levels, lack of a control group, or inadequate data on ALL prognosis. The gene discussed is VEGFA; the disease is acute lymphoblastic leukemia.